Summary
Colgate-Palmolive Company reported solid performance for the first quarter ended March 31, 2002. Net sales saw a slight decrease to $2,195.2 million from $2,212.2 million in the prior year, primarily due to unfavorable foreign currency exchange rates, although excluding these effects, sales would have increased. Profitability improved, with net income rising by 8% to $289.7 million and diluted earnings per share increasing by 11% to $0.49. This growth was driven by strong gross profit margins, which expanded to 54.8% from 53.4%, benefiting from cost reduction programs and manufacturing efficiencies. The company's strategic focus on new product introductions across its Oral, Personal, and Household Care segments, as well as its Pet Nutrition business, appears to be paying off, contributing to volume gains and market share improvements in key regions like North America and Europe. While certain international markets experienced currency headwinds and volume declines, the overall financial results demonstrate resilience and effective operational management. Investors should note the adoption of SFAS 142, which eliminated goodwill amortization, positively impacting reported earnings.
Key Highlights
- 1Net income increased by 8% to $289.7 million in Q1 2002 from $267.9 million in Q1 2001.
- 2Diluted Earnings Per Share (EPS) grew by 11% to $0.49 in Q1 2002 from $0.44 in Q1 2001.
- 3Gross profit margin improved to 54.8% from 53.4%, driven by cost reduction initiatives.
- 4Worldwide sales were $2,195.2 million, a slight decrease from $2,212.2 million, impacted by foreign currency fluctuations; excluding currency effects, sales would have risen 3%.
- 5The company adopted SFAS 142, eliminating goodwill amortization, which positively impacted net income and EPS, with a reported increase of $11.2 million and $0.02 per share for Q1 2001 on an adjusted basis.
- 6Operating cash flow for the quarter was $324.1 million, a slight decrease from $344.2 million, mainly due to higher tax payments.
- 7New product introductions across various segments, particularly in Oral Care and Personal Care, contributed to volume growth and market share gains in key regions.